All publications available within PubMed, Google Scholar, and Cochrane databases were reviewed for peer-reviewed journal articles, clinical trial data, and evidence-based reviews
Long-term safety data are still evolving, and optimal duration of treatment and maintenance strategies have yet to be defined
Gonzlez A, del Castillo-Vaquero A, Mir-Morn A, Tapia JA, Salido GM (2011a) Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology
individual tolerance varies based on lactose sensitivity and stomach capacity reduction
Isacson R, Nielsen E, Dannaeus K, Bertilsson G, Patrone C, Zachrisson O, Wikstrom L
[6] [7] 4 mg maintenance dose produces clinically meaningful weight loss in adults with obesity or overweight with at least one weight-related comorbidity